Compounds > naproxen
Page last updated: 2024-09-04

naproxen and Disease Models, Animal

naproxen has been researched along with Disease Models, Animal in 71 studies

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-19902 (2.82)18.7374
1990's10 (14.08)18.2507
2000's19 (26.76)29.6817
2010's34 (47.89)24.3611
2020's6 (8.45)2.80

Authors

AuthorsStudies
Doulgkeris, CM; Eleftheriou, PT; Galanakis, D; Gavalas, AM; Kourounakis, AP; Kourounakis, PN; Rekka, EA; Tsiakitzis, KC; Victoratos, P1
Bain, G; Beher, D; Chen, W; Jiang, X; Munoz, B; Peachey, J; Prasit, P; Shearman, MS; St-Jacques, R; Stock, N; Williamson, TL; Wrigley, JD1
Avdeef, A; Tam, KY1
Bilodeau, MT; Burgey, CS; Della Penna, K; Desai, R; Hartman, GD; Henze, DA; Kane, SA; Leitl, MD; Lemaire, W; Manley, PJ; Paone, DV; Trotter, BW; Urban, MO; White, RB; Yeh, S; Zartman, A1
Alonso-Castro, AJ; Campos-Xolalpa, N; Hernández-Munive, A; Pérez-González, C; Pérez-Gutiérrez, S; Zapata-Morales, JR1
Ertan, M; Kazkayasi, I; Okay, G; Ozadali-Sari, K; Sarigol, D; Somuncuoglu, EI; Tel, BC; Tozkoparan, B; Unsal-Tan, O; Uzgoren-Baran, A1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Barakat, A; Diaz-delCastillo, M; Heegaard, AM; Rice, ASC; Sena, ES; Soliman, N; Vollert, J; Zhang, XY1
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X1
Bommi, PV; Brown, PH; Chang, K; Francisco-Cruz, A; Gelincik, O; Kanth, P; Kopelovich, L; Lee, JJ; Lim, R; Lipkin, SM; Liu, DD; Lynch, PM; Marnett, LJ; Milne, GL; Mork, ME; Perloff, M; Revuelta, M; Reyes-Uribe, L; Richmond, E; Samadder, NJ; Sei, S; Shoemaker, RH; Solis, LM; Stoffel, EM; Szabo, E; Taggart, MW; Umar, A; Vilar, E; Vornik, L; Wistuba, II; Wu, W; You, YN1
Culbertson, MD; Galloway, J; Kadkoy, Y; Kanjilal, D; Lin, A; Moskonas, S; O'Connor, JP; Paglia, DN; Tompson, J; Wetterstrand, C1
Ahadova, A; Bork, P; Cortes, E; Deng, N; Edelmann, W; Elsaadi, A; Fuchs, V; Gebert, J; Gelincik, O; Hernandez-Sanchez, A; Katzenmaier, EM; Kloor, M; Lipkin, SM; Liu, S; Long, M; Marshall, JD; Nelius, N; Oezcan-Wahlbrink, M; Sei, S; Shoemaker, RH; Song, Y; Tosti, E; Umar, A; Urban, K; Vilar, E; von Knebel Doeberitz, M; Wei, L; Yuan, YP1
Alonso-Castro, AJ; Aragon-Martinez, OH; Isiordia-Espinoza, MA; Rangel-Velázquez, JE; Villanueva-Solís, LE; Zapata-Morales, JR1
Radhakrishnan, J; Radhakrishnan, R; Yellepeddi, VK1
McClain, SA; Singer, AJ; Towery, H1
Andreassen, KV; Dąbrowska, A; Ding, M; Henriksen, K; Karsdal, MA; Katri, A; Löfvall, H; Thudium, CS1
Antoniazzi, CTD; Dalenogare, DP; de Almeida, AS; De Prá, SD; Milioli, AM; Moresco, RN; Oliveira, SM; Pereira, GC; Peres, DS; Rigo, FK; Ritter, CDS; Stein, C; Trevisan, G1
Bolboacă, SD; Bulboacă, AC; Bulboacă, AE; Dogaru, G; Porfire, AS; Stănescu, IC; Suciu, ȘM; Tefas, LR1
Christoph, T; Leipelt, A; Pasqualon, T; Read, SJ; Robens, A; Rutten, K; Schiene, K1
Achterholt, N; Brodkin, J; Frank, D; Grippo, R; Gulinello, M; Gutzen, C; Hausfater, M1
Eissa, SI; Farrag, AM; Galeel, AA1
Gordish-Dressman, H; Miglietta, D; Miller, BK; Nagaraju, K; Ongini, E; Phadke, A; Quinn, JL; Tatem, KS; Uaesoontrachoon, K; Van Der Meulen, JH; Yu, Q1
Dutta, G; Ghosh, T; Goswami, AR; Sil, S1
Lanzi, C; Lucarini, L; Masini, E; Pini, A; Rosa, AC; Stark, H; Thurmond, RL; Veglia, E1
Biletska, L; Bondarchuk, T; Fomenko, I; Panasyuk, N; Sklyarov, A; Wallace, JL1
Deak, T; Hennessy, MB; Schiml, PA; Stafford, NP; Xanthos, ED; Yusko-Osborne, B1
Bula, N; Gavrilyuk, E; Khyrivska, D; Wallace, JL; Zayachkivska, O1
Amoruso, A; Bardelli, C; Brunelleschi, S; Dalli, J; Federici Canova, D; Fresu, LG; Miglietta, D; Perretti, M1
Bula, N; Havryluk, E; Hrytsevych, N; Khyrivska, D; Pshyk-Titko, I; Savytska, M; Zayachkivska, O1
Clementi, E; De Palma, C; Miglietta, D; Ongini, E; Pisa, V; Sciorati, C; Vergani, B; Villa, A1
Kim, BW; Kim, JH; Kwon, HJ1
Alonso-Castro, AJ; Carranza-Álvarez, C; Castellanos, LM; Domínguez, F; Martínez-Medina, RM; Pérez-Urizar, J; Zapata-Morales, JR1
Borey, AJ; Clark, JD; Cui, J; Donahue, F; Han, L; Hassan-Zahraee, M; Leach, MW; Lee, KL; Marusic, S; McKew, JC; Pelker, JW; Shen, MW; Shimizu, T; Stedman, NL; Thakker, P; Wolf, SF; Xu, X1
Dial, EJ; Lichtenberger, LM; Moore, JE; Romero, JJ1
Bandi, S; Enami, Y; Gupta, S; Joseph, B; Kapoor, S; Krohn, N1
Bai, Y; Gao, J; Li, Z; Wu, W; Zhang, W; Zhao, T; Zou, D1
Bhaskar, K; Herrup, K; Kounnas, MZ; Lamb, BT; Varvel, NH; Wagner, SL; Yang, Y1
Kumar, A; Kumar, P; Kumari, B1
Grubbs, CJ; Juliana, MM; Lubet, RA; Steele, VE1
Bianchi, C; Burgess, TA; Chu, LM; Feng, J; Laham, RJ; Robich, MP; Sellke, FW1
Barratt, MJ; Chang, M; Karim, F; Smith, S; Thorpe, A1
Angesjö, M; Berge, OG; Krekels, EH; Möller, KA; Sjögren, I; Visser, SA1
Barrio, JR; Chen, PP; Cole, GB; Cole, GM; Flood, DG; Frautschy, SA; Huang, SC; Jones, MR; Kepe, V; Liu, J; Satyamurthy, N; Small, GW; Teng, E; Trusko, SP; Yang, F1
Bercik, P; Bolla, M; Collins, SM; de Palma, G; Denou, E; Jury, J; McKnight, W; Ongini, E; Syer, S; Verdu, E; Vong, L; Wallace, JL1
Chu, LM; Feng, J; Heinl, R; Lassaletta, AD; Liu, Y; Robich, MP; Sellke, E; Sellke, FW; Xu, SH1
Elmes, SJ; McIntosh, F; Perkins, MN; Rashid, MH; Theberge, Y1
Gillet, P; Jaffré, B; Laugier, P; Loeuille, D; Netter, P; Saïed, A; Watrin, A1
Wallace, JL1
Boulet, J; Gottshall, S; Harrison, J; Mark, L; Pearson, M; Walker, K; Whiteside, GT1
Roach, JT; Sufka, KJ1
Ashton, P; Cardillo, JA; Costa, RA; Farah, ME; Jorge, R; Kuppermann, B; Melo, LA; Mitre, J; Morales, PH1
Afshari, HM; Dahners, LE; Hanson, CA; Weinhold, PS1
Chang, HI; Kim, JH; Kim, YS; Park, JJ; Song, GG1
Dhir, A; Kulkarni, SK; Naidu, PS1
Takahira, Y; Takeuchi, K; Tanaka, A; Yokota, A1
Kumar, A; Naidu, PS; Padi, SV; Seghal, N1
Burstein, R; Jakubowski, M; Kainz, V; Kosaras, B; Levy, D; Zhang, XC1
Barrett, TD; Hong, TT; Huang, J; Lucchesi, BR1
Distrutti, E; Fiorucci, S; Santucci, L1
Ballaron, SJ; De Young, LM; Puhvel, SM; Spires, DA; Young, JM1
de Medicis, R; Lussier, A1
Adami, A; Benoni, G; Conforti, A; Cuzzolin, L; Del Soldato, P; Lussignoli, S; Menestrina, F1
Gupta, SK; Joshi, S1
Medvedeff, ED; Nickerson-Nutter, CL1
Rioux, KP; Wallace, JL1
Guth, L; Krebs, CJ; Zhang, Z1
Sugita, T; Takata, I; Takeshita, M1
Kajiyama, G; Schurman, DJ; Smith, RL1
Bendele, AM; Benslay, DN; Hom, JT; Lee, SJ; Lindstrom, TD; Naismith, RW; Ruterbories, KJ; Spaethe, SM1
Bünger, C; Hansen, ES; He, SZ; Henriksen, TB; Hjortdal, VE; Kjølseth, D; Søballe, K1
Hsu, HP; Lane, N; Shortkroff, S; Sledge, CB; Spector, M; Thornhill, TS1

Reviews

4 review(s) available for naproxen and Disease Models, Animal

ArticleYear
Systematic review and meta-analysis of studies in which burrowing behaviour was assessed in rodent models of disease-associated persistent pain.
    Pain, 2022, 11-01, Volume: 163, Issue:11

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Celecoxib; Disease Models, Animal; Gabapentin; Ibuprofen; Male; Naproxen; Pain; Rats; Rodentia

2022
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022
Nitric oxide-releasing mesalamine: potential utility for treatment of inflammatory bowel disease.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35 Suppl 2

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Colitis; Cytokines; Disease Models, Animal; Humans; Leukocytes; Mesalamine; Naproxen; Nitric Oxide; Rats

2003
NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Disease Models, Animal; Duodenal Ulcer; Gastric Mucosa; Humans; Hydrogen Sulfide; Naproxen; Nitric Oxide; Nitric Oxide Donors; Stomach Ulcer

2007

Trials

2 trial(s) available for naproxen and Disease Models, Animal

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.
    Gut, 2021, Volume: 70, Issue:3

    Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; Colorectal Neoplasms, Hereditary Nonpolyposis; Dinoprostone; Disease Models, Animal; Female; Humans; Intestinal Mucosa; Male; Mice; Middle Aged; Naproxen

2021

Other Studies

66 other study(ies) available for naproxen and Disease Models, Animal

ArticleYear
Synthesis and pharmacochemical study of novel polyfunctional molecules combining anti-inflammatory, antioxidant, and hypocholesterolemic properties.
    Bioorganic & medicinal chemistry letters, 2006, Feb-15, Volume: 16, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antioxidants; Arthritis; Cholesterol; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Female; Inflammation; Pipecolic Acids; Proline; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triglycerides

2006
The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent.
    Bioorganic & medicinal chemistry letters, 2006, Apr-15, Volume: 16, Issue:8

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Flurbiprofen; Mice; Peptide Fragments

2006
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
    Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9

    Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis

2010
Decahydroquinoline amides as highly selective CB2 agonists: role of selectivity on in vivo efficacy in a rodent model of analgesia.
    Bioorganic & medicinal chemistry letters, 2011, Apr-15, Volume: 21, Issue:8

    Topics: Amides; Analgesics; Animals; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Pain; Quinolines; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2011
Synthesis, antinociceptive and anti-inflammatory effects of porphyrins.
    Bioorganic & medicinal chemistry, 2015, May-15, Volume: 23, Issue:10

    Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Disease Models, Animal; Edema; Erythrocytes; Hemolysis; Indomethacin; Male; Mice; Naproxen; Nociception; Pain; Pain Measurement; Porphyrins; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate

2015
Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modeling studies.
    Bioorganic & medicinal chemistry, 2015, May-15, Volume: 23, Issue:10

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Disease Models, Animal; Drug Design; Edema; Humans; Inflammation; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Naproxen; Nociception; Pain; Pain Measurement; Structure-Activity Relationship; Thiazoles; Thiones; Triazoles

2015
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Naproxen treatment inhibits articular cartilage loss in a rat model of osteoarthritis.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2021, Volume: 39, Issue:10

    Topics: Acetaminophen; Animals; Cartilage, Articular; Disease Models, Animal; Female; Naproxen; Osteoarthritis; Rats; Rats, Sprague-Dawley

2021
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
    Gastroenterology, 2021, Volume: 161, Issue:4

    Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Neoplasm; Cancer Vaccines; Colorectal Neoplasms, Hereditary Nonpolyposis; Databases, Genetic; Disease Models, Animal; Epitopes; Frameshift Mutation; Immunity, Cellular; Immunity, Humoral; Immunogenetic Phenomena; Mice, Inbred C57BL; Mice, Knockout; MutS Homolog 2 Protein; Naproxen; Peptide Fragments; Tumor Burden; Tumor Microenvironment; Vaccination; Vaccine Efficacy

2021
Synergism between Naproxen and Rutin in a Mouse Model of Visceral Pain.
    Drug development research, 2017, Volume: 78, Issue:5

    Topics: Acetic Acid; Administration, Oral; Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Naproxen; Pain Measurement; Rutin; Visceral Pain

2017
Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue.
    The Prostate, 2018, Volume: 78, Issue:2

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Celecoxib; Chromatography, Liquid; Comparative Effectiveness Research; Diclofenac; Disease Models, Animal; Ibuprofen; Inflammation; Male; Naproxen; Pelvic Pain; Prostate; Prostatitis; Rats; Rats, Sprague-Dawley; Tissue Distribution

2018
Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model.
    Burns : journal of the International Society for Burn Injuries, 2018, Volume: 44, Issue:6

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Burns; Disease Models, Animal; Disease Progression; Free Radical Scavengers; Ischemia; Naproxen; Necrosis; Random Allocation; Rats; Rats, Sprague-Dawley; Skin; Tadalafil; Vasodilator Agents

2018
Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model.
    Arthritis research & therapy, 2019, 02-22, Volume: 21, Issue:1

    Topics: Amylin Receptor Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Density Conservation Agents; Calcitonin; Collagen Type II; Disease Models, Animal; Female; Humans; Islet Amyloid Polypeptide; Naproxen; Pain; Pain Measurement; Rats, Inbred Lew; Receptors, Calcitonin; Swine

2019
Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma.
    Cellular and molecular neurobiology, 2019, Volume: 39, Issue:5

    Topics: Acetaminophen; Analgesics; Animals; Benzoxazines; Bone Neoplasms; Calcium; Cannabinoids; Cell Line, Tumor; Codeine; Disease Models, Animal; Female; Hyperalgesia; Locomotion; Mammary Neoplasms, Animal; Mice, Inbred BALB C; Morphine; Morpholines; Naphthalenes; Naproxen; Nociception; Pain Measurement

2019
Liposomal Curcumin Enhances the Effect of Naproxen in a Rat Model of Migraine.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Jul-09, Volume: 25

    Topics: Animals; Antioxidants; Curcumin; Disease Models, Animal; Drug Therapy, Combination; Inflammation; Male; Migraine Disorders; Naproxen; Oxidative Stress; Pain; Pain Measurement; Rats; Rats, Wistar

2019
Burrowing as a non-reflex behavioural readout for analgesic action in a rat model of sub-chronic knee joint inflammation.
    European journal of pain (London, England), 2014, Volume: 18, Issue:2

    Topics: Analgesia; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Chronic Disease; Disease Models, Animal; Ibuprofen; Inflammation; Knee Joint; Male; Naproxen; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Reflex

2014
Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice.
    Journal of neuroscience methods, 2014, Mar-15, Volume: 224

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autistic Disorder; Behavior, Animal; Carrageenan; Disease Models, Animal; Electronic Data Processing; Humans; Male; Mice; Mice, Inbred C57BL; Naproxen; Pain; Reproducibility of Results; Restraint, Physical; Stress, Psychological

2014
Non-carboxylic analogues of aryl propionic acid: synthesis, anti-inflammatory, analgesic, antipyretic and ulcerogenic potential.
    Drug research, 2014, Volume: 64, Issue:9

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antipyretics; Carrageenan; Disease Models, Animal; Edema; Fever; Inflammation; Male; Mice; Naphthalenes; Naproxen; Pain; Propionates; Rats; Rats, Wistar; Ulcer

2014
Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.
    Human molecular genetics, 2014, Jun-15, Volume: 23, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Function Tests; Hindlimb; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Naproxen; Nitric Oxide Donors; Prednisolone

2014
Effects of naproxen on immune responses in a colchicine-induced rat model of Alzheimer's disease.
    Neuroimmunomodulation, 2014, Volume: 21, Issue:6

    Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Brain; Colchicine; Cytokines; Disease Models, Animal; Hydrocortisone; Lymphocytes; Male; Naproxen; Nitrites; Phagocytes; Plaque, Amyloid; Rats; Reactive Oxygen Species; Spleen; Time Factors; Tubulin Modulators

2014
Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Inflammatory Agents; Bleomycin; Collagen; Cyclooxygenase 2; Deoxyguanosine; Disease Models, Animal; Goblet Cells; Indoles; Lung; Mice; Muscle, Smooth; Naproxen; Oxidative Stress; Peroxidase; Piperazines; Pneumonia; Pulmonary Fibrosis; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta

2014
Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.
    Stress (Amsterdam, Netherlands), 2014, Volume: 17, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Celecoxib; Disease Models, Animal; Epinephrine; Gastric Mucosa; Hydrogen Sulfide; Lipid Peroxidation; Male; Naproxen; Nitric Oxide; Nitric Oxide Synthase; Pyrazoles; Rats, Wistar; Restraint, Physical; Severity of Illness Index; Stomach Ulcer; Stress, Psychological; Sulfonamides

2014
Naproxen attenuates sensitization of depressive-like behavior and fever during maternal separation.
    Physiology & behavior, 2015, Volume: 139

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Body Temperature; Depression; Disease Models, Animal; Female; Guinea Pigs; Male; Maternal Deprivation; Motor Activity; Naproxen; Statistics, Nonparametric; Telemetry; Time Factors; Vocalization, Animal

2015
Exposure to non-steroid anti-inflammatory drugs (NSAIDs) and suppressing hydrogen sulfide synthesis leads to altered structure and impaired function of the oesophagus and oesophagogastric junction.
    Inflammopharmacology, 2015, Volume: 23, Issue:2-3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Esophagogastric Junction; Hydrogen Sulfide; Naproxen; Rats; Sulfides

2015
Characterization of the anti-inflammatory properties of NCX 429, a dual-acting compound releasing nitric oxide and naproxen.
    Life sciences, 2015, Apr-01, Volume: 126

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Interleukin-1beta; Matrix Metalloproteinase 9; Mice; Naproxen; NF-kappa B; Nitrates; Nitric Oxide; Nitric Oxide Donors; Peritonitis; Phagocytosis

2015
Effect of CCl4 and blocking H2S biosynthesis on oesophageal mucosa rats: model of nonerosive oesophagitis.
    Folia medica Cracoviensia, 2014, Volume: 54, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Tetrachloride; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Esophagitis, Peptic; Esophagus; Hydrogen Sulfide; Interleukin-10; Interleukin-17; Mucous Membrane; Naproxen; Nitric Oxide; Rats; Rats, Wistar

2014
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.
    Orphanet journal of rare diseases, 2015, Aug-22, Volume: 10

    Topics: Animals; Biological Availability; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Naproxen; Nitric Oxide Donors

2015
Protective Effect of 4-(3,4-Dihydroxyphenyl)-3-Buten-2-One from Phellinus linteus on Naproxen-Induced Gastric Antral Ulcers in Rats.
    Journal of microbiology and biotechnology, 2016, May-28, Volume: 26, Issue:5

    Topics: Agaricales; Animals; Anti-Ulcer Agents; Antioxidants; Butanones; Catalase; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Gastric Mucosa; Glutathione Peroxidase; Lipid Peroxidation; Male; Naproxen; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Superoxide Dismutase

2016
Antinociceptive Activity of an Ethanol Extract of Justicia spicigera.
    Drug development research, 2016, Volume: 77, Issue:4

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Ethanol; Justicia; Male; Medicine, Traditional; Mice; Mice, Inbred BALB C; Naproxen; Pain; Plant Extracts; Plant Leaves; Sleep Stages

2016
Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.
    Journal of neuroimmunology, 2008, Nov-15, Volume: 204, Issue:1-2

    Topics: Analysis of Variance; Animals; Benzoates; Cell Proliferation; Cells, Cultured; Cyclooxygenase Inhibitors; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Glycoproteins; Group IV Phospholipases A2; Hydroxyurea; Lipoxygenase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Myelin-Oligodendrocyte Glycoprotein; Naproxen; Peptide Fragments; Severity of Illness Index; Seveso Accidental Release; Sulfonamides; Th1 Cells; Time Factors

2008
Naproxen-PC: a GI safe and highly effective anti-inflammatory.
    Inflammopharmacology, 2009, Volume: 17, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Gastrointestinal Hemorrhage; Glycine max; Inflammation; Lecithins; Naproxen; Rats; Synovial Fluid

2009
Hepatic stellate cells promote hepatocyte engraftment in rat liver after prostaglandin-endoperoxide synthase inhibition.
    Gastroenterology, 2009, Volume: 136, Issue:7

    Topics: Analysis of Variance; Animals; Blotting, Western; Celecoxib; Cell Survival; Cells, Cultured; Disease Models, Animal; Female; Graft Survival; Hepatic Stellate Cells; Hepatocytes; Immunohistochemistry; Kupffer Cells; Male; Naproxen; Phagocytosis; Probability; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Random Allocation; Rats; Rats, Inbred F344; RNA, Messenger; Signal Transduction; Sulfonamides

2009
High-dose naproxen aggravates pancreatic fibrosis in a rat model of chronic pancreatitis.
    Pancreas, 2010, Volume: 39, Issue:3

    Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Fibrosis; Male; Naproxen; Pain; Pancreatitis, Chronic; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2010
NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.
    The Journal of clinical investigation, 2009, Volume: 119, Issue:12

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cell Cycle; Disease Models, Animal; Female; Humans; Ibuprofen; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microglia; Mutation; Naproxen; Neurons; Protein Processing, Post-Translational; Recombinant Proteins

2009
Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress.
    Neuroscience bulletin, 2010, Volume: 26, Issue:1

    Topics: Animals; Anxiety; Catalase; Chronic Disease; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Glutathione; Isoxazoles; Lactones; Lipid Peroxidation; Male; Meloxicam; Memory; Mice; Motor Activity; Naproxen; Nitrites; Random Allocation; Stress, Psychological; Sulfonamides; Sulfones; Thiazines; Thiazoles

2010
Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy.
    The Journal of urology, 2010, Volume: 183, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Gefitinib; Naproxen; Quinazolines; Rats; Rats, Inbred F344; Research Design; Resveratrol; Stilbenes; Urinary Bladder Neoplasms

2010
Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardium.
    The Journal of thoracic and cardiovascular surgery, 2010, Volume: 140, Issue:5

    Topics: Angiogenic Proteins; Animals; Apoptosis; Blood Pressure; Celecoxib; Collateral Circulation; Coronary Angiography; Coronary Circulation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Inflammation Mediators; Microcirculation; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Naproxen; Neovascularization, Physiologic; Oxidative Stress; Prostaglandins; Pyrazoles; Sulfonamides; Swine; Swine, Miniature; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Function, Left

2010
Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping.
    Molecular pain, 2010, Sep-16, Volume: 6

    Topics: Administration, Oral; Algorithms; Analgesics; Animals; Behavior, Animal; Disease Models, Animal; Freund's Adjuvant; Ganglia, Spinal; Gene Expression Profiling; Gene Expression Regulation; Injections; Male; Mannitol; Naproxen; Nociceptors; Oleic Acids; Oligonucleotide Array Sequence Analysis; Pain; Phenoxybenzamine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Up-Regulation

2010
Pharmacokinetic-pharmacodynamic modeling of the inhibitory effects of naproxen on the time-courses of inflammatory pain, fever, and the ex vivo synthesis of TXB2 and PGE2 in rats.
    Pharmaceutical research, 2011, Volume: 28, Issue:7

    Topics: Animals; Antipyretics; Arthritis; Dinoprostone; Disease Models, Animal; Fever; Gene Expression Regulation; Inhibitory Concentration 50; Male; Models, Chemical; Naproxen; Oxytocics; Pain; Rats; Rats, Sprague-Dawley; T-Box Domain Proteins; Time Factors

2011
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment.
    Neurobiology of disease, 2011, Volume: 43, Issue:3

    Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Binding, Competitive; Disease Models, Animal; Fluorine Radioisotopes; Humans; Naproxen; Nitriles; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Rats, Transgenic

2011
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
    Gastroenterology, 2011, Volume: 141, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Actinobacteria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bifidobacterium; Celecoxib; Colon; Denaturing Gradient Gel Electrophoresis; Disease Models, Animal; Drug Interactions; Gastrointestinal Hemorrhage; Hematocrit; Jejunum; Lansoprazole; Male; Naproxen; Omeprazole; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Pyrazoles; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Time Factors

2011
High-fat diet alters prostanoid balance and perfusion in ischemic myocardium of naproxen-treated swine.
    Surgery, 2011, Volume: 150, Issue:3

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Coronary Circulation; Dietary Fats; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heart Function Tests; Hypercholesterolemia; Immunoblotting; Myocardial Ischemia; Naproxen; Perfusion; Prostaglandins; Random Allocation; Reference Values; Sensitivity and Specificity; Swine; Vascular Endothelial Growth Factor A

2011
Pharmacological validation of early and late phase of rat mono-iodoacetate model using the Tekscan system.
    European journal of pain (London, England), 2013, Volume: 17, Issue:2

    Topics: Alkylating Agents; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Chronic Disease; Dexamethasone; Dinoprostone; Disease Models, Animal; Duloxetine Hydrochloride; Hindlimb; Iodoacetates; Male; Morphine; Muscle Fibers, Skeletal; Naproxen; Neurons, Afferent; Pain Measurement; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Restraint, Physical; Synovial Fluid; Thiophenes; Weight-Bearing

2013
Effects of antiinflammatory drugs on arthritic cartilage: a high-frequency quantitative ultrasound study in rats.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cartilage, Articular; Dexamethasone; Disease Models, Animal; Male; Naproxen; Rats; Rats, Wistar; Ultrasonography

2003
Pharmacological characterisation of a rat model of incisional pain.
    British journal of pharmacology, 2004, Volume: 141, Issue:1

    Topics: Amines; Analgesics; Animals; Behavior, Animal; Celecoxib; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Etoricoxib; Foot; Gabapentin; gamma-Aminobutyric Acid; Hindlimb; Hyperalgesia; Indomethacin; Male; Morphine; Muscle, Skeletal; Naproxen; Nociceptors; Pain Threshold; Pain, Postoperative; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sulfonamides; Sulfones; Time Factors; Weight-Bearing

2004
Characterization of the chick carrageenan response.
    Brain research, 2003, Dec-24, Volume: 994, Issue:2

    Topics: Analgesics, Opioid; Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents; Behavior, Animal; Carrageenan; Chickens; Cyclooxygenase Inhibitors; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Edema; Hyperalgesia; Inflammation; Morphine; Naproxen; Pain Measurement; Reaction Time; Time Factors

2003
An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.
    The British journal of ophthalmology, 2004, Volume: 88, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biodegradation, Environmental; Disease Models, Animal; Drug Combinations; Drug Implants; Electroretinography; Eye Enucleation; Eye Injuries; Fluorouracil; Naproxen; Rabbits; Retinal Detachment; Vitreoretinopathy, Proliferative

2004
The effect of analgesic agents on the healing rat medial collateral ligament.
    The American journal of sports medicine, 2005, Volume: 33, Issue:5

    Topics: Acetaminophen; Administration, Oral; Analgesics; Animals; Butorphanol; Collateral Ligaments; Disease Models, Animal; Dose-Response Relationship, Drug; Lactones; Naproxen; Piroxicam; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Sulfones; Weight-Bearing; Wound Healing

2005
Protective effect of astaxanthin on naproxen-induced gastric antral ulceration in rats.
    European journal of pharmacology, 2005, May-02, Volume: 514, Issue:1

    Topics: Adjuvants, Immunologic; Animals; beta Carotene; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione Peroxidase; Male; Malondialdehyde; Naproxen; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Superoxide Dismutase; Time Factors; Xanthophylls

2005
Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes.
    Addiction biology, 2005, Volume: 10, Issue:4

    Topics: Alcohol Withdrawal Delirium; Alcoholism; Animals; Behavior, Animal; Brain; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Injections, Intraperitoneal; Lactones; Male; Mice; Naproxen; Neuroprotective Agents; Sulfonamides; Sulfones

2005
Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Disease Models, Animal; Enterobacteriaceae; Flurbiprofen; Gastrointestinal Motility; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Lactones; Male; Naproxen; Nitric Oxide; Nitric Oxide Synthase Type II; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfones; Time Factors; Up-Regulation

2006
Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats.
    European journal of pharmacology, 2006, Dec-03, Volume: 551, Issue:1-3

    Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cognition Disorders; Colchicine; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Injections, Intraventricular; Isoxazoles; Lipid Peroxidation; Male; Maze Learning; Memory; Naproxen; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Space Perception; Spatial Behavior; Sulfonamides; Time Factors

2006
Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion.
    Neuroscience, 2007, Aug-24, Volume: 148, Issue:2

    Topics: Action Potentials; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Infusions, Intravenous; Male; Migraine Disorders; Naproxen; Pain; Pain Threshold; Physical Stimulation; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Skin; Time Factors; Trigeminal Nerve

2007
Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:1

    Topics: Acetylcholine; Animals; Arachidonic Acid; Benzofurans; Carotid Arteries; Coronary Circulation; Coronary Vessels; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Epoprostenol; Inflammation; Ligation; Lipopolysaccharides; Naproxen; Platelet Aggregation; Propionates; Pyrazoles; Receptors, Epoprostenol; Sulfonamides; Thrombosis; Time Factors; Vasodilation; Vasodilator Agents

2008
Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne.
    The Journal of investigative dermatology, 1984, Volume: 83, Issue:5

    Topics: Acne Vulgaris; Animals; Benzoyl Peroxide; Disease Models, Animal; Erythromycin; Female; Fluocinolone Acetonide; Inflammation; Injections, Intradermal; Naproxen; Propionibacterium acnes; Pyrazoles; Rats; Rats, Inbred Strains; Tetracycline; Tretinoin

1984
Correlation between ossification and inflammation using a rat experimental model.
    The Journal of rheumatology. Supplement, 1983, Volume: 11

    Topics: Animals; Arthritis; Arthritis, Experimental; Disease Models, Animal; Indomethacin; Naproxen; Ossification, Heterotopic; Phenylbutazone; Rats; Spine; Spondylitis, Ankylosing

1983
Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen.
    Pharmacological research, 1995, Volume: 31, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Digestive System; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Female; Male; Naproxen; Rats; Rats, Sprague-Dawley; Stomach Ulcer

1995
Role of naproxen as anti-oxidant in selenite cataract.
    Ophthalmic research, 1994, Volume: 26, Issue:4

    Topics: Animals; Antioxidants; Cataract; Crystallins; Disease Models, Animal; Female; Glutathione; Injections, Intraperitoneal; Lens, Crystalline; Male; Malondialdehyde; Naproxen; Organ Size; Oxidative Stress; Rats; Rats, Wistar; Sodium Selenite

1994
The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
    Arthritis and rheumatism, 1996, Volume: 39, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Chronic Disease; Disease Models, Animal; Drug Combinations; Exudates and Transudates; Female; Hydroxyurea; Inflammation; Leukotriene B4; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Naproxen; Prostaglandin-Endoperoxide Synthases; Quinolines; Time Factors; Zymosan

1996
Mast cells do not contribute to nonsteroidal anti-inflammatory drug-induced gastric mucosal injury in rodents.
    Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Degranulation; Dexamethasone; Disease Models, Animal; Gastric Mucosa; Indomethacin; Male; Mast Cells; Mice; Naproxen; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stomach Ulcer

1996
Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response.
    Experimental neurology, 1997, Volume: 143, Issue:1

    Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Female; Naproxen; Necrosis; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries

1997
Pathological evaluation of effect of anti-rheumatic drugs on type II collagen-induced arthritis in Lewis rats.
    Experimental animals, 1997, Volume: 46, Issue:2

    Topics: Animals; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Collagen; Dexamethasone; Disease Models, Animal; Female; Humans; Immunoglobulin G; Naproxen; Rats; Rats, Inbred Lew

1997
Staphylococcal septic arthritis: antibiotic and nonsteroidal anti-inflammatory drug treatment in a rabbit model.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 1997, Volume: 15, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Cartilage, Articular; Ceftriaxone; Cephalosporins; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Female; Glycosaminoglycans; Hydroxyproline; Knee Joint; Naproxen; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Synovial Fluid; Synovitis

1997
Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arthritis, Experimental; Collagen; Diamines; Diclofenac; Dinoprostone; Disease Models, Animal; Female; Interleukin-1; Leukotriene B4; Male; Naproxen; Oxazines; Phenols; Piroxicam; Rats; Rats, Inbred Lew; Thromboxane B2

1992
[99mTc]diphosphonate uptake and hemodynamics in experimental arthritis: effect of naproxen in the canine carrageenan injection model.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 1992, Volume: 10, Issue:5

    Topics: Animals; Arthritis; Bone and Bones; Capillary Permeability; Carrageenan; Diphosphonates; Disease Models, Animal; Dogs; Growth Plate; Hemodynamics; Homeostasis; Injections; Microspheres; Naproxen; Regional Blood Flow; Technetium; Technetium Compounds

1992
Tissue changes around loose prostheses. A canine model to investigate the effects of an antiinflammatory agent.
    Clinical orthopaedics and related research, 1990, Issue:261

    Topics: Animals; Anti-Inflammatory Agents; Bone Resorption; Cells, Cultured; Dinoprostone; Disease Models, Animal; Dogs; Hip Joint; Hip Prosthesis; Interleukin-1; Knee Joint; Knee Prosthesis; Naproxen; Prosthesis Failure; Radiography; Reoperation

1990